Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B‐cell lymphomaOlalekan O. Oluwole, Tom van Meerten, Peter A. McSweeney et al.|British Journal of Haematology|2021Cited by 217
KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 resultsBijal Shah, William G. Wierda, Michael R. Bishop et al.|Blood|2021Cited by 204
End of phase I results of ZUMA-3, a phase 1/2 study of KTE-X19, anti-CD19 chimeric antigen receptor (CAR) T cell therapy, in adult patients (pts) with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL).Bijal Shah, William G. Wierda, Michael Bishop et al.|Journal of Clinical Oncology|2019Cited by 38
Prophylactic Steroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Relapsed/Refractory Large B Cell Lymphoma (R/R LBCL)Olalekan O. Oluwole, Tom van Meerten, Krimo Bouabdallah et al.|Transplantation and Cellular Therapy|2021Cited by 7